Jeff Balser Archive — Page 1 of 5

July 15, 2026

University of Michigan’s David C. Miller chosen to succeed Jeff Balser as Vanderbilt Health’s President and CEO and Dean of Vanderbilt University School of Medicine

Miller’s selection as the new senior leader for Vanderbilt Health and Vanderbilt University School of Medicine finalizes an extensive national search by the VH Board of Directors to identify Balser’s successor.  

May 6, 2026

Growth, resilience and care: Vanderbilt Health’s priorities for 2026

The health system’s regional footprint continues to grow, with new and planned facilities extending Vanderbilt Health’s reach across Middle Tennessee.

April 29, 2026

Physician, author Ezekiel Emanuel shares six rules for a long, healthy life

Ezekiel Emanuel, MD, is widely known for his work at the intersection of medicine, ethics and public policy.

Jeff Balser, MD, PhD, talks about VUMC’s ongoing commitment to its core missions during the recent Leadership Assembly. (photo by Donn Jones)
March 12, 2026

Vanderbilt Health President and CEO Jeff Balser to retire 

Jeff Balser’s announcement culminates a career-long journey that began at Vanderbilt in the mid-1980s as a medical student and doctoral dual degree candidate.

Jeff Balser, MD, PhD, speaks during the Spring Faculty Meeting. (photo by Susan Urmy)
June 6, 2025

Spring Faculty Meeting provides important updates on School of Medicine’s progress

During Vanderbilt University School of Medicine’s Spring Faculty Meeting and Awards Program, held May 30, Jeff Balser, MD, PhD, President and CEO of Vanderbilt University Medical Center and Dean of the School of Medicine, shared important updates.

Jeff Balser, MD, PhD, talks about VUMC’s ongoing commitment to its core missions during the recent Leadership Assembly. (photo by Donn Jones)
May 8, 2025

With strategic vision, VUMC navigates evolving health care landscape

Through cost savings initiatives that began earlier this year, the Medical Center is positioning itself to thrive despite reductions in research funding from the NIH and changes impacting reimbursements from Medicare and Medicaid.